Sangamo Therapeutics, Inc. (SGMO)
NASDAQ: SGMO · Real-Time Price · USD
0.7168
-0.1032 (-12.59%)
Mar 31, 2025, 12:29 PM EDT - Market open

Sangamo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
161213965151,0932,207
Upgrade
Market Cap Growth
120.88%120.88%-81.28%-52.90%-50.50%127.45%
Upgrade
Enterprise Value
156201-12046141,554
Upgrade
Last Close Price
0.821.020.543.147.5015.61
Upgrade
PS Ratio
2.863.680.554.629.8718.68
Upgrade
PB Ratio
7.669.351.161.752.914.44
Upgrade
P/TBV Ratio
9.359.351.162.493.885.56
Upgrade
P/FCF Ratio
----14.23
Upgrade
P/OCF Ratio
----12.99
Upgrade
EV/Sales Ratio
2.703.48-1.835.5413.15
Upgrade
EV/FCF Ratio
----10.01
Upgrade
Debt / Equity Ratio
1.341.340.460.150.130.09
Upgrade
Debt / FCF Ratio
-----0.27
Upgrade
Asset Turnover
0.430.430.480.170.130.15
Upgrade
Quick Ratio
1.021.021.782.532.994.51
Upgrade
Current Ratio
1.131.131.982.693.124.60
Upgrade
Return on Equity (ROE)
-185.39%-185.39%-136.47%-57.37%-40.86%-26.05%
Upgrade
Return on Assets (ROA)
-46.05%-46.05%-19.63%-19.59%-13.80%-10.27%
Upgrade
Return on Capital (ROIC)
-70.52%-70.52%-31.12%-33.04%-23.80%-15.93%
Upgrade
Earnings Yield
-58.43%-46.02%-267.59%-37.37%-16.32%-5.48%
Upgrade
FCF Yield
-40.21%-31.67%-255.31%-47.38%-23.48%7.03%
Upgrade
Buyback Yield / Dilution
-15.62%-15.62%-13.02%-6.76%-7.53%-19.92%
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q